PharmGen Science

PharmGen Science Current Liabilities

The Current Liabilities of PharmGen Science (004720.KS) as of Oct 9, 2026 is 4.21 B KRW. In the previous year, Current Liabilities was 54.16 B KRW — a change of -92.23% (lower).

Current Liabilities

4.21 BKRW

YoY

-92.23%

Last updated:

Current Liabilities of PharmGen Science is 2025 4.21 B KRW. Current Liabilities of PharmGen Science was 2024 54.16 B KRW. It decreases by -92.23% lower compared to the previous year.

The PharmGen Science Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
53.30 B KRW
Jan 1, 2019
48.30 B KRW
Jan 1, 2020
38.57 B KRW
Jan 1, 2021
70.71 B KRW
Jan 1, 2022
52.25 B KRW
Jan 1, 2023
51.35 B KRW
Jan 1, 2024
54.16 B KRW
Jan 1, 2025
4.21 B KRW
The PharmGen Science Current Liabilities history
YEARCurrent LiabilitiesYoY
4.21 BKRW-92.23%
54.16 BKRW+5.46%
51.35 BKRW-1.70%
52.25 BKRW-26.11%
70.71 BKRW+83.32%
38.57 BKRW-20.14%
48.30 BKRW-9.38%
53.30 BKRW+369.37%
11.36 BKRW-64.35%
31.85 BKRW+85.40%
17.18 BKRW-36.92%
27.23 BKRW+57.92%
17.25 BKRW+22.08%
14.13 BKRW-36.65%
22.30 BKRW-23.43%
29.12 BKRW-2.62%
29.91 BKRW-42.18%
51.72 BKRW+30.53%
39.62 BKRW+28.32%
30.88 BKRW+12.23%
27.51 BKRW+88.31%
14.61 BKRW-36.05%
22.85 BKRW+186.97%
7.96 BKRW+131.83%
3.43 BKRW-30.77%
4.96 BKRW-8.59%
5.43 BKRW-19.32%
6.73 BKRW+1.83%
6.60 BKRW—
Access this data via the Eulerpool API
Get Free API Key

PharmGen Science Stock analysis

What does PharmGen Science do? PharmGen Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmGen Science stock

Current Liabilities of PharmGen Science is 4.21 B KRW in 2025.

Current Liabilities of PharmGen Science changed from 54.16 B KRW to 4.21 B KRW, representing a -92.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities PharmGen Science since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's PharmGen Science historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — PharmGen Science

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — PharmGen Science